安吉戴纳米克斯

最新新闻

• 评级变动
  H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2024/12/10
• 评级变动
  AngioDynamics (ANGO) Gets a Buy From H.C. Wainwright
  TipRanks · 2024/10/4
• 评级变动
  Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/1/7
• 评级变动
  Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2025/1/10
• 评级变动
  H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2025/4/8
• 评级变动
  H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2025/1/10
• 评级变动
  CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/1/7
• H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2025/10/3
• H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2024/10/4
• 评级变动
  CCORF Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2025/1/10
• 评级变动
  Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2024/10/5
• Freedom Capital Markets Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/4/6
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)
  TipRanks · 2026/5/29
• Lake Street Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2025/8/13
• 评级变动
  CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2024/12/10
• H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/4/6

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。